FDA announces 2025 to 2026 flu virus strain

The U.S. Food and Drug Administration has selected the influenza virus strains that manufacturers should use to develop their 2025 to 2026 flu vaccines.
Flu case numbers were found to be higher compared with previous years, according to a news article from Reuters.
The decision regarding the virus strain came after the cancellation of a scheduled meeting with the Vaccine and Related Biological Products Advisory Committee. The FDA expects the flu vaccines to be available as usual in the next flu season.
Read more: Reuters
The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.